Bernanke Spurs Stocks
Health Care: Drugs
Amgen Inc (AMGN: NASDAQ)
$104.53 0.29 | 0.28%
05/22/13 - 04:00 PM ET
Portfolios with AMGN
- Portfolio NameUser Type
- ContributorTechnical Setups for the We...
- ContributorHigh Volume Technicals for ...
- UserDividend Stocks
- ContributorTechnical Setups for the We...
- ContributorTechnical Setups for the We...
- UserStevo
- ContributorPotential Dividend Hikes fo...
- UserMike Fatah's Mega Stock Por...
- UserGFNN Stockdiagnostics 23
- UserLong Term Stock Picks
Latest AMGN Headlines from TheStreet
- The Next Big Thing In Biotech: Large-Cap Earnings
04.18.13 | 09:04 am - Amgen Inc Stock Buy Recommendation Reiterated (AMGN) 04.15.13 | 10:04 am
- Today's Featured Drugs Gainer: Amgen Inc (AMGN) 04.12.13 | 05:04 pm
- 4 Stocks Driving The Drugs Industry Higher 04.12.13 | 01:04 pm
- Amgen Stock Hits New 52-Week High (AMGN) 04.10.13 | 12:04 pm
- 5 Health Care Stocks Ready to Break Out 04.09.13 | 11:04 am
- Biotech Multiples Are Soaring But M&A Is Dead 04.08.13 | 12:04 pm
- Amgen Inc (AMGN): Today's Favorite Drugs Gainer 04.04.13 | 05:04 pm
- 5 Stocks Dragging In The Health Care Sector 04.03.13 | 01:04 pm
- Amgen Inc Stock Buy Recommendation Reiterated (AMGN) 04.03.13 | 10:04 am
Press Releases for AMGN
- Amgen Announces Webcast Of 2013 First Quarter Financial Results - PR Newswire 04.18.13 | 04:04 pm
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma - PR Newswire 03.19.13 | 06:03 pm
- Amgen Announces 2013 Second Quarter Dividend - PR Newswire 03.06.13 | 04:03 pm
- Amgen To Present At The Cowen And Company 33rd Annual Health Care Conference - PR Newswire 03.01.13 | 04:03 pm
- Amgen Statement On Government Budget Analysis For Oral-Only Treatments For Dialysis Patients - PR Newswire 02.22.13 | 05:02 pm
- Amgen Announces Call For Nominations For 2013 Breakaway From Cancer® Champions - PR Newswire 02.08.13 | 09:02 am
- Amgen To Webcast 2013 Business Review Meeting On February 7 - PR Newswire 01.31.13 | 04:01 pm
- Amgen Announces Results From Phase 3 PAVES Study Evaluating Neulasta® (pegfilgrastim) In Patients With Colorectal Cancer - PR Newswire 01.26.13 | 10:01 am
- Amgen Backs States' Efforts To Enact Biosimilar Legislation That Allows For Substitution And Supports Patient Safety - PR Newswire 01.25.13 | 07:01 pm
Partner Headlines for AMGN
- Market Close Report: NASDAQ Composite index closes at 3,496.43 down -2.54 points - NASDAQ 05.20.13 | 08:05 pm
- Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 14, 2013 - NASDAQ 05.13.13 | 11:05 am
- Short Interest in Vertex Rises, in Celgene Falls - Benzinga 05.11.13 | 10:05 am
- Amgen, Inc. (AMGN): Today's Most Compelling Stock Buy - NASDAQ 05.09.13 | 04:05 pm
- The Secret Stock Picks Of This Multi Billion Quant Hedge Fund - Seeking Alpha 05.09.13 | 09:05 am
- Techne Corporation (TECH) Ex-Dividend Date Scheduled for May 08, 2013 - NASDAQ 05.07.13 | 01:05 pm
- Leading Biotechs Act Well But Be Careful Not To Chase - Investor's Business Daily 05.06.13 | 06:05 pm
- Top Fund Buys Focus On Defensive Stocks, Housing - Investor's Business Daily 05.02.13 | 05:05 pm
- UPDATE: Goldman Sachs Upgrades Amgen to CL-Buy on Favorable Catalysts, Upside Potential - Benzinga 05.01.13 | 09:05 am
- Futures Slip On Soft Jobs Data; Amgen, Humana Advance - Investor's Business Daily 05.01.13 | 08:05 am
